BeOne Medicines (ONC) Net Income Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -115.51% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 59.59% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -10.08% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -73.01% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1,228.66% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 17,802.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,802.13% |
| Dec 31, 2025 | 143.79% |
| Sep 30, 2025 | 202.88% |
| Jun 30, 2025 | 178.34% |
| Mar 31, 2025 | 100.51% |
| Dec 31, 2024 | 58.68% |
| Sep 30, 2024 | -156.33% |
| Jun 30, 2024 | 68.41% |
| Mar 31, 2024 | 27.92% |
| Dec 31, 2023 | 17.47% |
| Sep 30, 2023 | 138.64% |
| Jun 30, 2023 | 32.63% |
| Mar 31, 2023 | 19.94% |
| Dec 31, 2022 | 24.61% |
| Sep 30, 2022 | -27.26% |
| Jun 30, 2022 | -17.78% |
| Mar 31, 2022 | -754.48% |
| Dec 31, 2021 | -17.97% |
| Sep 30, 2021 | -2.69% |
| Jun 30, 2021 | -42.82% |
| Mar 31, 2021 | 118.22% |
| Dec 31, 2020 | -29.09% |
| Sep 30, 2020 | -38.22% |
| Jun 30, 2020 | -291.28% |
| Mar 31, 2020 | -117.14% |
| Dec 31, 2019 | -45.44% |
| Sep 30, 2019 | -113.62% |
| Jun 30, 2019 | 45.50% |
| Mar 31, 2019 | -59.89% |
| Dec 31, 2018 | -168.64% |
| Sep 30, 2018 | -223.20% |
| Jun 30, 2018 | -159.91% |
| Mar 31, 2018 | -107.64% |
| Dec 31, 2017 | -164.06% |
| Sep 30, 2017 | 430.43% |
| Jun 30, 2017 | -151.53% |
| Mar 31, 2017 | -130.09% |
| Dec 31, 2016 | -252.84% |
| Sep 30, 2016 | -153.55% |
| Jun 30, 2016 | -327.65% |
| Mar 31, 2016 | -115.44% |